tradingkey.logo

tradingkey.logo
怜玢


Rapport Therapeutics Inc

RAPP
りォッチリストに远加
26.150USD
+0.300+1.16%
終倀 11-13 16:00ET
1.55B時䟡総額
損倱額盎近12ヶ月PER

Rapport Therapeutics Incに぀いお 䌁業名

Rapport Therapeutics, Inc. is a clinical-stage biotechnology company engaged in discovering and developing small-molecule precision medicines for patients with neurological or psychiatric disorders. It has made discoveries related to the function of receptor-associated proteins (RAPs) in the brain. Its RAP technology platform enables a differentiated approach to generate precision small molecule product candidates with the potential to overcome many limitations of conventional neurology drug discovery. Its precision neuroscience pipeline includes its lead investigational drug, RAP-219, designed to achieve neuroanatomical specificity through its selective targeting of a RAP expressed in only discrete regions of the brain. It is pursuing RAP-219 as a treatment for refractory focal epilepsy, bipolar mania and diabetic peripheral neuropathic pain. Additional preclinical and late-stage discovery stage programs are also underway, including targeting chronic pain and hearing disorders.

Rapport Therapeutics Inc プロフィヌル


䌁業コヌドRAPP
䌚瀟名Rapport Therapeutics Inc
䞊堎日Jun 07, 2024
最高経営責任者「CEO」Ceesay (Abraham N)
埓業員数69
蚌刞皮類Ordinary Share
決算期末Jun 07
本瀟所圚地99 High Street
郜垂BOSTON
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号02110
電話番号18573218020
りェブサむトhttps://www.rapportrx.com/
䌁業コヌドRAPP
䞊堎日Jun 07, 2024
最高経営責任者「CEO」Ceesay (Abraham N)

Rapport Therapeutics Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Abraham N. (Abe) Ceesay
Mr. Abraham N. (Abe) Ceesay
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
654.95K
-1.03%
Dr. Steven M. (Steve) Paul, M.D.
Dr. Steven M. (Steve) Paul, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
519.31K
+8.02%
Mr. David Bredt, M.D., Ph.D.
Mr. David Bredt, M.D., Ph.D.
Chief Scientific Officer
Chief Scientific Officer
393.07K
-0.64%
Ms. Cheryl Gault
Ms. Cheryl Gault
Chief Operating Officer
Chief Operating Officer
139.91K
-7.15%
Dr. Jeffrey Sevigny, M.D.
Dr. Jeffrey Sevigny, M.D.
Chief Medical Officer
Chief Medical Officer
107.29K
--
Mr. Troy A. Ignelzi
Mr. Troy A. Ignelzi
Chief Financial Officer
Chief Financial Officer
15.50K
+35.48%
Dr. Ramiro (Raymond) Sanchez, M.D.
Dr. Ramiro (Raymond) Sanchez, M.D.
Independent Director
Independent Director
3.60K
--
Dr. Swamy Yeleswaram, Ph.D.
Dr. Swamy Yeleswaram, Ph.D.
Chief Development Officer
Chief Development Officer
--
--
Dr. James I. Healy, M.D., Ph.D.
Dr. James I. Healy, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Reid Huber, Ph.D.
Mr. Reid Huber, Ph.D.
Independent Director
Independent Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Abraham N. (Abe) Ceesay
Mr. Abraham N. (Abe) Ceesay
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
654.95K
-1.03%
Dr. Steven M. (Steve) Paul, M.D.
Dr. Steven M. (Steve) Paul, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
519.31K
+8.02%
Mr. David Bredt, M.D., Ph.D.
Mr. David Bredt, M.D., Ph.D.
Chief Scientific Officer
Chief Scientific Officer
393.07K
-0.64%
Ms. Cheryl Gault
Ms. Cheryl Gault
Chief Operating Officer
Chief Operating Officer
139.91K
-7.15%
Dr. Jeffrey Sevigny, M.D.
Dr. Jeffrey Sevigny, M.D.
Chief Medical Officer
Chief Medical Officer
107.29K
--
Mr. Troy A. Ignelzi
Mr. Troy A. Ignelzi
Chief Financial Officer
Chief Financial Officer
15.50K
+35.48%

よくある質問

Rapport Therapeutics Incの䞊䜍5名の株䞻は誰ですか


Rapport Therapeutics Incの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Abraham N. (Abe) Ceesay

Rapport Therapeutics IncRAPPの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Rapport Therapeutics Incの株匏を保有しおいる機関は264瀟あり、保有株匏の総垂堎䟡倀は玄57.38Mで、党䜓の119.98%を占めおいたす。2025Q4ず比范しお、機関の持ち株は6399926.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。